Résultats de recherche
30 mai 2024 · Pharming Group develops and commercializes protein replacement therapies and precision medicines for the unserved rare disease patient. Find out the latest news, events, financial results and career opportunities on their website.
- About Us
Pharming is a global biopharmaceutical company dedicated to...
- Products
Products - Home | Pharming Group N.V.
- Pipeline
In 2021, Pharming announced a strategic collaboration with...
- Investors
Investors - Home | Pharming Group N.V.
- News
Pharming Group N.V. is pleased to announce its recognition...
- Careers
Pharming Group N.V. is a global biopharmaceutical company...
- Contact
Pharming has its headquarters in Leiden, the Netherlands. We...
- Language Verander taal
Pharming Group N.V. Vondellaan 47 2332 AA Leiden Nederland...
- About Us
Le cours de l'action PHARMING GROUP PHARM sur Boursorama : historique de la cotation sur Euronext Amsterdam, graphique, actualités, consensus des analystes et informations...
3 juin 2024 · Pharming is a rare disease company that develops and commercializes protein replacement therapies and precision medicines. It is headquartered in the Netherlands and listed on Euronext Amsterdam and Nasdaq, with a focus on transforming the lives of patients with rare, debilitating, and life threatening diseases.
Find the latest Pharming Group N.V. (PHAR) stock quote, history, news and other vital information to help you with your stock trading and investing.
3 juin 2024 · Pharming Group N.V. is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024. Read more. 2024. Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025.
Find the latest Pharming Group N.V. (PHAR) stock quote, history, news and other vital information to help you with your stock trading and investing.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening...